Impact News +++ Interim profits surge at M&S despite ′onslaught′ of costs (ShareCast) +++ MARKS AND SPENCER Aktie +4,17%

CERIBELL Aktie

>Aktienkurs

22.66 EUR -10.3% (TradegateBSX)

Ask: 23.115 EUR / 130 Stück

Bid: 23.11 EUR / 250 Stück

Tagesumsatz: 20 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>Performance

1 Woche: -0,8%

1 Monat: +15,2%

3 Monate: +53,1%

6 Monate: 0%

1 Jahr: 0%

laufendes Jahr: 0%

>Aktie

Profil:

Ceribell Inc. is a medical technology company focused on acute-care neurodiagnostics. Ceribell develops the Ceribell System, a point-of-care EEG platform designed to help clinicians detect and manage serious neurological conditions at the bedside. It..
>Volltext..

Insiderhandel:

>Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>Peer Group

>Chart & Kurs - NASDAQ

>Alle News

04.11.26 - 03:15	CeriBell, Inc. (CBLL) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
	CeriBell, Inc. (CBLL) delivered earnings and revenue surprises of +4.00% and +0.70%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?...

04.11.26 - 02:30	Compared to Estimates, CeriBell, Inc. (CBLL) Q3 Earnings: A Look at Key Metrics (Zacks)
	The headline numbers for CeriBell, Inc. (CBLL) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

04.11.26 - 02:30	CeriBell outlines $115M-$117M 2026 revenue, while launching delirium monitoring and previewing Omni for 2027 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.11.26 - 23:36	Earnings Call: CeriBell steigert Q3-Umsatz 2026 um 30 % – EPS verfehlt Erwartungen (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

03.11.26 - 22:39	CeriBell GAAP EPS of -$0.55 misses by $0.04, revenue of $29.3M beats by $0.14M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.11.26 - 22:06	Ceribell Reports Third Quarter 2026 Financial Results (GlobeNewswire EN)
	SUNNYVALE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the third quarter ended September 30, 2026....

02.11.26 - 13:03	Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution (GlobeNewswire EN)
	Commercial launch follows successful pilot, with customers reporting improved clinical decision-making and greater confidence in care decisions Commercial launch follows successful pilot, with customers reporting improved clinical decision-making and greater confidence in care decisions...

28.10.26 - 21:06

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire EN)

SUNNYVALE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Scott Blumberg, CFO, will participate in a fireside chat at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York City. The fireside chat will take place on Wednesday, November 11, 2026, at 7:00 a.m. Pacific Standard Time / 10:00 a.m. Eastern Standard Time....

20.10.26 - 22:06

Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026 (GlobeNewswire EN)

SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the third quarter of 2026 after the close of trading on Tuesday, November 3, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on November 3, 2026....

03.10.26 - 01:01	Insiderhandel: Chief Technology Officer verkauft Aktien von CeriBell im Wert von 119145 USD (Insiderkauf)
	Woo, Raymond - Vorstand - Tag der Transaktion: 2026-10-01...

30.09.26 - 13:01	Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis (GlobeNewswire EN)
	New clearance to further simplify bedside EEG interpretation and enable more informed interventions for patients of all ages across multiple indications New clearance to further simplify bedside EEG interpretation and enable more informed interventions for patients of all ages across multiple indications...

18.09.26 - 06:01	Insiderhandel: President and CEO verkauft Aktien von CeriBell im Wert von 521775 USD (Insiderkauf)
	Chao, Xingjuan - Vorstand - Tag der Transaktion: 2026-09-15...

18.09.26 - 06:01	Insiderhandel: Chief Financial Officer verkauft Aktien von CeriBell im Wert von 21150 USD (Insiderkauf)
	Blumberg, Scott - Vorstand - Tag der Transaktion: 2026-09-15...

17.09.26 - 11:00	Biotech Stocks At 52-Week Highs - BlossomHill Therapeutics +18% On Positive Trial Data, Adaptive Biotechnologies, Illumina, CeriBell, Neogen (AFX)
	SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on September 16, 2026, driven by positive results from clinical trials or an upcoming conference participation.BlossomHill......

11.09.26 - 08:01	Insiderhandel: Chief Technology Officer verkauft Aktien von CeriBell im Wert von 118901 USD (Insiderkauf)
	Woo, Raymond - Vorstand - Tag der Transaktion: 2026-09-08...

11.09.26 - 08:01	Insiderhandel: Senior VP, Finance and PAO verkauft Aktien von CeriBell im Wert von 224451 USD (Insiderkauf)
	Foehr, David - Vorstand - Tag der Transaktion: 2026-09-08...

05.09.26 - 02:01	Insiderhandel: President and CEO verkauft Aktien von CeriBell im Wert von 973079 USD (Insiderkauf)
	Chao, Xingjuan - Vorstand - Tag der Transaktion: 2026-09-02...

05.09.26 - 02:01	Insiderhandel: Chief Financial Officer verkauft Aktien von CeriBell im Wert von 16300 USD (Insiderkauf)
	Blumberg, Scott - Vorstand - Tag der Transaktion: 2026-09-02...

27.08.26 - 02:01	Insiderhandel: Senior VP, Finance and PAO verkauft Aktien von CeriBell im Wert von 20573 USD (Insiderkauf)
	Foehr, David - Vorstand - Tag der Transaktion: 2026-08-24...

27.08.26 - 02:01	Insiderhandel: Chief Technology Officer verkauft Aktien von CeriBell im Wert von 47536 USD (Insiderkauf)
	Woo, Raymond - Vorstand - Tag der Transaktion: 2026-08-21...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Bei der Erzählung jeder ungerechten Handlung, wer auch ihr Opfer oder wo auch ihr Schauplatz sei, gerät mein Herz in Flammen, als ob die Wirkung auf mich zurückfiele. - Jean-Jacques Rousseau

Partner: >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram